|
|
|
Insider
Information: |
Lawlis V Bryan |
Relationship: |
|
City: |
Hayward |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
33,140 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,937,198 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
33,140 |
|
|
Total
Value |
$2,937,198 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2023-05-23 |
33,140 |
2009-05-12 |
0 |
Premium* |
|
Geron Corporation |
GERN |
|
2024-05-15 |
0 |
2023-05-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
71 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2018-09-27 |
4 |
AS |
$97.93 |
$210,550 |
D/D |
(2,150) |
19,160 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2019-09-17 |
4 |
AS |
$74.47 |
$279,263 |
D/D |
(3,750) |
23,590 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2020-03-17 |
4 |
AS |
$75.39 |
$282,713 |
D/D |
(3,750) |
18,980 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2019-06-17 |
4 |
AS |
$81.08 |
$304,050 |
D/D |
(3,750) |
23,590 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2019-12-17 |
4 |
AS |
$83.36 |
$312,600 |
D/D |
(3,750) |
23,590 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2018-04-17 |
4 |
AS |
$85.00 |
$318,750 |
D/D |
(3,750) |
14,860 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2018-01-02 |
4 |
AS |
$88.84 |
$333,150 |
D/D |
(3,750) |
14,860 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2017-06-16 |
4 |
AS |
$90.00 |
$337,500 |
D/D |
(3,750) |
15,910 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2017-09-15 |
4 |
AS |
$91.26 |
$342,225 |
D/D |
(3,750) |
15,910 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2012-05-15 |
4 |
S |
$38.51 |
$342,769 |
D/D |
(8,900) |
13,400 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2012-05-15 |
4/A |
S |
$38.51 |
$342,769 |
D/D |
(8,900) |
10,900 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2020-03-16 |
4 |
AS |
$76.52 |
$352,757 |
D/D |
(4,610) |
18,980 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2022-04-14 |
4 |
AS |
$83.66 |
$355,555 |
D/D |
(4,250) |
23,970 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2022-01-14 |
4 |
AS |
$87.61 |
$372,343 |
D/D |
(4,250) |
23,970 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2020-06-05 |
4 |
AS |
$107.46 |
$476,048 |
D/D |
(4,430) |
18,850 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2021-04-15 |
4 |
AS |
$76.90 |
$576,750 |
D/D |
(7,500) |
18,850 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2016-07-22 |
4 |
AS |
$95.01 |
$608,064 |
D/D |
(6,400) |
13,860 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2021-02-16 |
4 |
AS |
$87.41 |
$655,575 |
D/D |
(7,500) |
18,850 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2016-11-09 |
4 |
AS |
$95.00 |
$712,500 |
D/D |
(7,500) |
13,860 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2017-03-01 |
4 |
AS |
$95.00 |
$712,500 |
D/D |
(7,500) |
13,860 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2015-11-16 |
4 |
S |
$107.27 |
$804,530 |
D/D |
(7,500) |
11,850 |
0 |
- |
|
71 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|